» Articles » PMID: 12884017

The Monocyte Locomotion Inhibitory Factor Produced by Entamoeba Histolytica Inhibits Induced Nitric Oxide Production in Human Leukocytes

Overview
Journal Parasitol Res
Specialty Parasitology
Date 2003 Jul 29
PMID 12884017
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The monocyte locomotion inhibitory factor, an anti-inflammatory pentapeptide produced by Entamoeba histolytica, inhibits the in vitro production of nitric oxide induced by cytokines (INF-gamma, TNF-alpha) or PMA in human leukocytes. This can be added to the other previously reported functional effects of this factor, such as the inhibition of monocyte locomotion and the synthesis of reactive oxygen intermediates in both monocytes and neutrophils. The decreased nitric oxide production may interfere with the killing of amebas by neutrophils in the early invasive stages of amebiasis, when oxidative mechanisms are used [reactive oxygen and nitrogen intermediates either individually or synergistically via peroxynitrite (ONOO(-))], and in the advanced stages, when both non-oxidative and oxidative (including nitric oxide) mechanisms are employed by macrophages. Diminished nitric oxide production by leukocytes may also contribute to the paucity of late inflammatory components in amebic abscess of the liver and other amebic lesions.

Citing Articles

Functional Characterization of an Interferon Gamma Receptor-Like Protein on Entamoeba histolytica.

Pulido-Ortega J, Talamas-Rohana P, Munoz-Ortega M, Aldaba-Muruato L, Martinez-Hernandez S, Campos-Esparza M Infect Immun. 2019; 87(11).

PMID: 31427448 PMC: 6803330. DOI: 10.1128/IAI.00540-19.


Calreticulin Induces the Expression of Cytokines in Peripheral Blood Mononuclear Cells Isolated From Patients With Amebic Liver Abscess.

Gonzalez Rivas E, Ximenez C, Nieves-Ramirez M, Moran Silva P, Partida-Rodriguez O, Hernandez E Front Cell Infect Microbiol. 2018; 8:358.

PMID: 30406037 PMC: 6202884. DOI: 10.3389/fcimb.2018.00358.


Immune Evasion Mechanisms of Entamoeba histolytica: Progression to Disease.

Begum S, Quach J, Chadee K Front Microbiol. 2015; 6:1394.

PMID: 26696997 PMC: 4678226. DOI: 10.3389/fmicb.2015.01394.


Peroxynitrite and peroxiredoxin in the pathogenesis of experimental amebic liver abscess.

Pacheco-Yepez J, Jarillo-Luna R, Gutierrez-Meza M, Abarca-Rojano E, Larsen B, Campos-Rodriguez R Biomed Res Int. 2014; 2014:324230.

PMID: 24822193 PMC: 4009108. DOI: 10.1155/2014/324230.


Monocyte locomotion inhibitory factor produced by E. histolytica improves motor recovery and develops neuroprotection after traumatic injury to the spinal cord.

Bermeo G, Ibarra A, Garcia E, Flores-Romero A, Rico-Rosillo G, Marroquin R Biomed Res Int. 2013; 2013:340727.

PMID: 24294606 PMC: 3835973. DOI: 10.1155/2013/340727.


References
1.
Kretschmer R, Rico G, Gimenez J . A novel anti-inflammatory oligopeptide produced by Entamoeba histolytica. Mol Biochem Parasitol. 2001; 112(2):201-9. DOI: 10.1016/s0166-6851(00)00367-4. View

2.
Rico G, Kretschmer R . The monocyte locomotion inhibitory factor (MLIF) produced by axenically grown Entamoeba histolytica fails to affect the locomotion and the respiratory burst of human eosinophils in vitro. Arch Med Res. 1997; 28 Spec No:233-4. View

3.
Kretschmer R, Collado M, Pacheco M, Salinas M, Lecuona M, Castro E . Inhibition of human monocyte locomotion by products of axenically grown E. histolytica. Parasite Immunol. 1985; 7(5):527-43. DOI: 10.1111/j.1365-3024.1985.tb00097.x. View

4.
Ialenti A, Ianaro A, Moncada S, Di Rosa M . Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol. 1992; 211(2):177-82. DOI: 10.1016/0014-2999(92)90526-a. View

5.
Ding A, Nathan C, Stuehr D . Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol. 1988; 141(7):2407-12. View